About this Journal Submit a Manuscript Table of Contents
International Journal of Vascular Medicine
Volume 2012 (2012), Article ID 906954, 6 pages
http://dx.doi.org/10.1155/2012/906954
Clinical Study

Evaluation of Serum Biomarkers for Patients at Increased Risk of Stroke

1Clinic of Vascular Surgery, Klinikum Rechts der Isar der Technischen Universitaet Muenchen, Ismaninger Straße 22, 81675 Munich, Germany
2Department of Neurology, Klinikum Rechts der Isar der Technischen Universitaet Muenchen, Germany

Received 30 September 2011; Revised 6 January 2012; Accepted 6 January 2012

Academic Editor: Karl A. Illig

Copyright © 2012 Pelisek Jaroslav et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Rothwell, S. A. Gutnikov, and C. P. Warlow, “Reanalysis of the final results of the European carotid surgery trial,” Stroke, vol. 34, no. 2, pp. 514–523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Pelisek, M. Rudelius, P. Zepper et al., “Multiple biological predictors for vulnerable carotid lesions,” Cerebrovascular Diseases, vol. 28, no. 6, pp. 601–610, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. Virmani, A. P. Burke, A. Farb, and F. D. Kolodgie, “Pathology of the Vulnerable Plaque,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. C13–C18, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. M. Wahlgren, W. Zheng, W. Shaalan, J. Tang, and H. S. Bassiouny, “Human carotid plaque calcification and vulnerability: relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology,” Cerebrovascular Diseases, vol. 27, no. 2, pp. 193–200, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. A. Chalela, “Evaluating the carotid plaque: going beyond stenosis,” Cerebrovascular Diseases, vol. 27, no. 1, pp. 19–24, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. R. Moreno, K. R. Purushothaman, M. Sirol, A. P. Levy, and V. Fuster, “Neovascularization in human atherosclerosis,” Circulation, vol. 113, no. 18, pp. 2245–2252, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. C. Newby, “Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture,” Physiological Reviews, vol. 85, no. 1, pp. 1–31, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. W. Koenig, “Cardiovascular biomarkers: added value with an integrated approach?” Circulation, vol. 116, no. 1, pp. 3–5, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. N. Ferri, R. Paoletti, and A. Corsini, “Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation,” Current Opinion in Lipidology, vol. 17, no. 5, pp. 495–501, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. Lind, “Circulating markers of inflammation and atherosclerosis,” Atherosclerosis, vol. 169, no. 2, pp. 203–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. T. Wu and L. L. Wu, “Linking inflammation and atherogenesis: soluble markers identified for the detection of risk factors and for early risk assessment,” Clinica Chimica Acta, vol. 366, no. 1-2, pp. 74–80, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. M. Turu, J. Krupinski, E. Catena et al., “Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound,” Atherosclerosis, vol. 187, no. 1, pp. 161–169, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. B. Alvarez, C. Ruiz, P. Chacćn, J. Alvarez-Sabin, and M. Matas, “Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis,” Journal of Vascular Surgery, vol. 40, no. 3, pp. 469–475, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. Sapienza, L. di Marzo, V. Borrelli et al., “Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression,” European Journal of Vascular and Endovascular Surgery, vol. 28, no. 1, pp. 89–97, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. J. Molloy, M. M. Thompson, E. C. Schwalbe, P. R. Bell, A. R. Naylor, and I. M. Loftus, “Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation,” European Journal of Vascular and Endovascular Surgery, vol. 27, no. 4, pp. 409–413, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. C. D. Bicknell, D. Peck, N. M. Lau et al., “The relationship between plasma MMP-1, -7, -8 and -13 levels and embolic potential during carotid endoluminal intervention,” European Journal of Vascular and Endovascular Surgery, vol. 28, no. 5, pp. 500–507, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. P. Heider, J. Pelisek, H. Poppert, and H. H. Eckstein, “Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease,” Vascular and Endovascular Surgery, vol. 43, no. 6, pp. 551–560, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. J. N. Redgrave, P. Gallagher, J. K. Lovett, and P. M. Rothwell, “Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study,” Stroke, vol. 39, no. 6, pp. 1722–1729, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. N. E. Redgrave, J. K. Lovett, P. J. Gallagher, and P. M. Rothwell, “Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study,” Circulation, vol. 113, no. 19, pp. 2320–2328, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. T. J. Wang, P. Gona, M. G. Larson et al., “Multiple biomarkers for the prediction of first major cardiovascular events and death,” The New England Journal of Medicine, vol. 355, no. 25, pp. 2631–2639, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. H. Thakore, C. Y. Guo, M. G. Larson et al., “Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study),” American Journal of Cardiology, vol. 99, no. 11, pp. 1598–1602, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. C. Warlow, B. Farrell, A. Fraser, P. Sandercock, and J. Slattery, “Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST),” The Lancet, vol. 351, no. 9113, pp. 1379–1387, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. E. R. DeLong, D. M. DeLong, and D. L. Clarke-Pearson, “Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach,” Biometrics, vol. 44, no. 3, pp. 837–845, 1988. View at Scopus
  24. V. Lemaitre and J. D'Armiento, “Matrix metalloproteinases in development and disease,” Birth Defects Research C, vol. 78, no. 1, pp. 1–10, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. P. Libby, G. Sukhova, R. T. Lee, and Z. S. Galis, “Cytokines regulate vascular functions related to stability of the atherosclerotic plaque,” Journal of Cardiovascular Pharmacology, vol. 25, no. 2, supplement 2, pp. S9–S12, 1995. View at Scopus
  26. S. Chaturvedi, A. Bruno, T. Feasby et al., “Carotid endarterectomy—an evidence-based review: report of the therapeutics and technology assessment subcommittee of the American academy of neurology,” Neurology, vol. 65, no. 6, pp. 794–801, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. T. Ito and U. Ikeda, “Inflammatory cytokines and cardiovascular disease,” Current Drug Targets, vol. 2, no. 3, pp. 257–265, 2003. View at Scopus